Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 25/10/27

Trade details

Type
Insider sale
Amount
$1,243,995.72
Shares · price
2,937 sh · $423.56 a share
Held after
1,193 sh
Trade date
25/10/24
Filed
25/10/27
Days to filing
3 days

Sold 71.1% of holdings

Share of holding sold
71.1%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/24~25/11/23

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $775.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $537.5K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.3K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $477.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $446.5K

    Filed 10/02

Martine A. Rothblatt, Chairman — sold $1.2M of United Therapeutics UTHR · 71.1% of holdings · 10b5-1 plan | Whalegun